Based on previous findings of the pro-inflammatory roles of saturated fat and TLR-2 signalling that adversely effect the vasculature, we hypothesized that feeding saturated fat as the primary fat source would exacerbate NASH and that TLR-2 deficiency would protect against NASH pathogenesis. The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatohepatitis.